Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Speciality MedicinesBOM:544738 -6.76%21 PB Ratio is 1.93 as of Aug. 09, 2026, which is 23% below its 10-year median of 2.51. GuruFocus rates BOM:544738 with a GF Score™ of 21/100. The stock has 3 warning signs investors should review. Among 924 Drug Manufacturers companies, Speciality Medicines ranks better than 51.41% on this metric.
The historical rank and industry rank for Speciality Medicines's PB Ratio or its related term are showing as below:
BOM:544738'
s PB Ratio Range Over the Past 10 Years
Min: 1.56 Med: 2.51 Max: 4.08
Current: 1.93
During the past 5 years, Speciality Medicines's highest PB Ratio was 4.08. The lowest was 1.56. And the median was 2.51.
BOM:544738's PB Ratio is ranked better than 51.41% of 924
companies
in the Drug Manufacturers industry
Industry Median: 1.95
vs BOM:544738: 1.93
During the past 12 months, Speciality Medicines's average Book Value Per Share Growth Rate was 134.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 129.00% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Speciality Medicines was 150.60% per year. The lowest was 129.00% per year. And the median was 139.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Speciality Medicines PB Ratio Related Terms
Speciality Medicines PB Ratio Historical Data
* Premium members only.
The historical data trend for Speciality Medicines's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Speciality Medicines PB Ratio Chart
Speciality Medicines Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
PB Ratio
0.00
0.00
0.00
0.00
1.55
Speciality Medicines Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
PB Ratio
0.00
0.00
0.00
0.00
1.55
BOM:544738 vs ZTS: PB Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Speciality Medicines's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Speciality Medicines PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Speciality Medicines's PB Ratio distribution charts can be found below:
* The bar in red indicates where Speciality Medicines's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Speciality Medicines (BOM:544738) has a PB Ratio of 1.93 as of Aug. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Speciality Medicines and its competitors. This is 23% below median its historical median of 2.51. Over the past decade, Speciality Medicines' PB Ratio has ranged from 1.56 to 4.08. According to the industry distribution chart, Speciality Medicines ranks #449 out of 924 companies in the Drug Manufacturers industry, placing it in the top 48.6%.
Is Speciality Medicines' PB Ratio too high?
Speciality Medicines' current PB Ratio of 1.93 is 23% below median its 10-year median of 2.51. Over the past 10 years, this metric has ranged from a low of 1.56 to a high of 4.08. The Drug Manufacturers industry median PB Ratio is 1.95. Speciality Medicines' value of 1.93 is 1% below this industry median. Based on the distribution chart, Speciality Medicines ranks #449 out of 924 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Speciality Medicines has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Speciality Medicines' PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Speciality Medicines ranks #449 out of 924 companies for PB Ratio. This puts Speciality Medicines in the upper half of its industry. The industry median PB Ratio is 1.95. Speciality Medicines' value of 1.93 is 1% below this benchmark. Historically, Speciality Medicines' own PB Ratio has ranged from 1.56 to 4.08 over the past decade. While the company's 10-year median is 2.51 vs. the industry median of 1.95, Speciality Medicines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.95, based on 924 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Speciality Medicines's current PB Ratio of 1.93 is 1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Speciality Medicines and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Speciality Medicines's current PB Ratio is 1.93, which is 23% below median its own 10-year median of 2.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Speciality Medicines stock overvalued right now?
Speciality Medicines (BOM:544738) has a current PB Ratio of 1.93. The current PB Ratio is 1.93, which is 23% below median its 10-year median of 2.51 and 1% below the Drug Manufacturers industry median of 1.95. Speciality Medicines' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Speciality Medicines (BOM:544738), the current PB Ratio is 1.93 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Speciality Medicines Ltd is engaged in the marketing and distribution of finished formulations of specialty pharmaceutical products, comprising oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases. Its product range includes various dosage forms such as tablets, capsules, syrups, injections, infusions, inhalers, sprays, and topical formulations. The company operates through two business models: (a) Manufacturing, through contract manufacturing basis, and (b) Marketing and distribution of specialty pharmaceutical products sourced from manufacturers. The majority of the company's revenue is derived from the sale of its projects, mainly through exports to other countries.
21GF Score
Get the complete analysis for BOM:544738
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544738 has been successfully added to your 
